FLUID-BAG MULTI - containers for liquid and semi-solid pharmaceuticals - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

FLUID-BAG MULTI - containers for liquid and semi-solid pharmaceuticals

Fluid-Bag Ltd provides comprehensive 900 and 1000 litre flexible IBC systems for liquid and semi-solid products, including filling and discharging equipment. The GMP compliant container system is designed to guarantee uniform liquid, maximise payload and minimise discharge residue (0.5% residue).

The MULTI container combines the flexibility and space-saving advantages of both single-trip and multi-trip containers. The container consists of:

  • a replaceable, single-trip inner container
  • a reusable multi-trip transport bag
  • a reusable steel transport pallet with 4 steel poles.

Alternative liner combinations are available, gamma irradiation is also possible. The container can be used for external transports, intermediate storage, for transport between production, store room and packing department etc.

The FLUID-BAG system is used for storage and transportation of a wide range of liquids where protection from bacteria, particle, oxidation, taste or moisture contamination is needed. The containers are widely used for ointments, lotions, suspensions and other liquid or semi-solid products.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here